During treatment, your healthcare provider may recommend repeat thyroid function tests after significant weight loss, following any levothyroxine dose adjustments or if symptoms of thyroid imbalance develop
Efforts like this continue to strengthen the bridge between late-phase research and routine care, helping ensure that therapeutic decisions are informed by evidence grounded in real-world clinical realities
Despite this, Novo Nordisk has been heavily advertising this medication, claiming it can help individuals lose weight and keep it off
Research on managing type 2 diabetes and metabolic health consistently points to a diet built around high-fiber foods, quality protein, and healthy fats while limiting saturated fat and refined carbohydrates
Weight-loss and peptide programs are managed one-on-one by Kasey Heintzelman, FNP-C, with a tailored plan after a Wellness Consultation or Oral consultation
orforglipron has filed for FDA approval Molecular type : Orforglipron is a small molecule